876379-74-7

Usage

Uses

Used in Pharmaceutical Synthesis:
6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid is used as a building block for the synthesis of pharmaceutical compounds. Its unique structure and potential reactivity allow for the development of new drugs with improved therapeutic properties.
Used in Coordination Chemistry:
In coordination chemistry, 6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid serves as a ligand, enabling the formation of coordination complexes with various metal ions. This application expands its utility in the development of new materials and catalysts.
Used in Material Development:
6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid is used in the development of new materials due to its unique structure and potential reactivity. Its incorporation into materials can lead to novel properties and applications in various industries.
Used as a Research Tool in Organic Synthesis:
6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid is used as a research tool in organic synthesis, providing insights into the reactivity and properties of heterocyclic aromatic compounds. Its study can contribute to the advancement of synthetic methodologies and the discovery of new chemical reactions.
Used as a Research Tool in Medicinal Chemistry:
In medicinal chemistry, 6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid is used as a research tool to explore its potential as a lead compound for drug discovery. Its unique structure and reactivity can inspire the design of new therapeutic agents with improved efficacy and selectivity.
Overall, 6-bromoH-pyrazolo[1,5-a]pyridine-2-carboxylic acid's diverse applications across various fields highlight its significance as a versatile chemical entity with potential for further exploration and development.

InChI:InChI=1/C8H5BrN2O2/c9-5-1-2-6-3-7(8(12)13)10-11(6)4-5/h1-4H,(H,12,13)

Upstream product

• 1176413-42-5 6-bromo-pyrazolo[1,5-a]pyridine-2,3-dicarboxylic acid dimethyl ester 
• 626-55-1 3-Bromopyridine 

Downstream Products

• 1541188-97-9 C₂₇H₃₅N₅O₃Si 
• 1541188-96-8 C₂₄H₃₀N₄O₅SSi 
• 1541188-95-7 C₂₃H₂₈N₄O₃Si 
• 1541184-63-7 2-morpholin-4-ylmethyl-6-[4-(2H-pyrazol-3-yl)phenoxy]pyrazolo[1,5-a]pyridine 

Relevant academic research and scientific papers

TETRAHYDROPYRAZOLO-PYRAZINYL-DIHYDROIMIDAZOLONE OR TETRAHYDROPYRAZOLO-PYRIDINYL-DIHYDROIMIDAZOLONE COMPOUNDS AND METHODS OF USING SAME

The application relates to a compound of Formula (I) : or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.

INHIBITORS OF LEUKOTRIENE PRODUCTION

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein A1, A2, L1 and B are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these com-pounds in the treatment of various diseases and disorders, and processes for preparing these compounds.

METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders

INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF

The invention relates to neuroreceptor-active carboxamide-substituted indolizine derivatives of general formula (I) wherein X represents a group of general formula (X1).